nardosinone has been researched along with angiotensin ii in 1 studies
Studies (nardosinone) | Trials (nardosinone) | Recent Studies (post-2010) (nardosinone) | Studies (angiotensin ii) | Trials (angiotensin ii) | Recent Studies (post-2010) (angiotensin ii) |
---|---|---|---|---|---|
17 | 0 | 13 | 38,152 | 1,089 | 7,413 |
Protein | Taxonomy | nardosinone (IC50) | angiotensin ii (IC50) |
---|---|---|---|
Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.002 | |
Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0055 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.004 | |
Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0011 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du, M; Gao, L; Huang, D; Huang, K; Wang, B; Wang, WS; Yang, L | 1 |
1 other study(ies) available for nardosinone and angiotensin ii
Article | Year |
---|---|
Nardosinone protects H9c2 cardiac cells from angiotensin II-induced hypertrophy.
Topics: Angiotensin II; Animals; Cardiotonic Agents; Cell Line; Cell Size; Hypertrophy; MAP Kinase Signaling System; Myoblasts, Cardiac; Phosphatidylinositol 3-Kinases; Polycyclic Sesquiterpenes; Proto-Oncogene Proteins c-akt; Rats; RNA, Messenger; Sesquiterpenes; TOR Serine-Threonine Kinases | 2013 |